Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-13

Clinical Trial Update: Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE) [Phase 3]

View source ↗

Summary

Phase 3 EPIONE trial evaluating tradipitant versus placebo in atopic dermatitis has completed and posted results on 2024-05-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tradipitant (tradipitant)

Snippet

Sponsor: Vanda Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2024-05-13